PropertyValue
?:abstract
  • People with epilepsy (PWE) are neither more likely to be infected by the coronavirus nor are they more likely to have severe COVID-19 manifestations because they suffer from epilepsy. However, management of COVID-19 in PWE may be more complicated than that in other individuals. Drug-drug interactions could pose significant challenges and cardiac, hepatic, or renal problems, which may happen in patients with severe COVID-19, may require adjustment to antiepileptic drugs (AEDs). In this review, we first summarize the potential drug-drug interactions between AEDs and drugs currently used in the management of COVID-19. We then summarize other challenging issues that may happen in PWE, who have COVID-19 and are receiving treatment.
?:creator
?:doi
?:doi
  • 10.1007/s10072-020-04549-5
?:journal
  • Neurol_Sci
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/67b0a6be41ae6b00a224f1a3e781fcdfb7a4ba09.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7320844.xml.json
?:pmcid
?:pmid
?:pmid
  • 32594268.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Management of COVID-19 in people with epilepsy: drug considerations
?:type
?:year
  • 2020-06-27

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ogmckwpq>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ogmckwpq>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all